Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Incy crawled date : 2021 - 10 - 28 save search
Incyte Announces the Validation of the European Marketing Authorization Application for Ruxolitinib Cream in Vitiligo
Published: 2021-10-28 (Crawled : 12:15) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.49%
H: 1.01%
C: 0.69%
europe application
Innovent and NeoCura Announce Strategic Collaboration to Study the Combination Therapy of Sintilimab and Neoantigen Vaccine NEO_PLIN2101 for Cancer Treatment in China
Published: 2021-10-28 (Crawled : 00:00) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.0%
H: 2.63%
C: 1.28%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.49%
H: 1.01%
C: 0.69%
treatment china therapy collaboration cancer vaccine
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
RWOD | $9.54 19.3% 16.18% 6.1M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.